Please use this identifier to cite or link to this item:
Title: Combined BRAF and MEK inhibition in BRAF-mutant NSCLC.
Austin Authors: Rivalland, Gareth;Mitchell, Paul L R 
Affiliation: Department of Medical Oncology, Austin Health, Olivia Newton-John Cancer Wellness & Research Centre, Heidelberg, Victoria, Australia
University of Melbourne, Victoria, Australia
Thoracic Alliance for Cancer Trials, Milton, QLD, Australia
Issue Date: Jul-2016 2016-06-06
Publication information: Lancet Oncology 2016; 17(7): 860-862
DOI: 10.1016/S1470-2045(16)30203-0
Journal: The Lancet Oncology
PubMed URL: 27283865
Type: Journal Article
Appears in Collections:Journal articles

Show full item record

Google ScholarTM


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.